Warenkorb

0.00
HPLC-getestetCOA jede ChargeEU-VersandSEPA · sichere ZahlungNur für Forschungszwecke
PEPTIQA BIOTECHSermorelin5 mgPurity 98.5% · RUO

Excellent

Ocena 4.8 / 5 — zgodnja ocena kakovosti

Peptiqa Reviews

Zgodnja ocena kakovosti — po prvem verified nakupu lahko kupci objavijo mnenje.

Sermorelin

5 mg98.5% purityLot #SERMOR-2026-001

Art.-Nr. der gewählten Abmessung: PEP-SERM-5MG

Sermorelin (GRF 1-29) is a laboratory-produced peptide modeled after the first 29 amino acids of the body's natural growth hormone-releasing hormone (GHRH). By acting directly on the pituitary gland, it encourages the natural synthesis and release of human growth hormone (hGH) while maintaining the body's built-in hormonal control systems. Unlike direct HGH administration, Sermorelin relies on physiological feedback mechanisms, helping prevent unnaturally elevated growth hormone levels. Previously marketed as Geref®, it received FDA approval for the diagnosis and treatment of growth hormone deficiency in pediatric patients. Scientific investigations have linked Sermorelin therapy to improvements in lean muscle mass, sleep quality, insulin sensitivity, and overall vitality. Because pituitary feedback remains intact, its safety profile is generally viewed as more favorable than that of exogenous HGH replacement.
€91.50inkl. MwSt.
auf Lager (40)

Mengenpreise

MengeStückpreisErsparnis
1 vial91.50
3 vials (−7%)85.40−7%
5 vials (−12%)80.52−12%
Nakup & zberi 75 točk!

Ocene in mnenja

Prijavite se in ocenite izdelek po prejetem naročilu. Anmelden

Analysezertifikat

Lab-verifiziert
COA vor dem Kauf ansehen — Transparenz garantiert
Forschungsprofil

Sermorelinwissenschaftliches Profil

Inhalt dient Bildungs- und Forschungszwecken. Research Use Only.

  • Sermorelin (GRF 1-29) is a laboratory-produced peptide modeled after the first 29 amino acids of the body's natural growth hormone-releasing hormone (GHRH). By acting directly on the pituitary gland, it encourages the natural synthesis and release of human growth hormone (hGH) while maintaining the body's built-in hormonal control systems. Unlike direct HGH administration, Sermorelin relies on physiological feedback mechanisms, helping prevent unnaturally elevated growth hormone levels. Previously marketed as Geref®, it received FDA approval for the diagnosis and treatment of growth hormone deficiency in pediatric patients. Scientific investigations have linked Sermorelin therapy to improvements in lean muscle mass, sleep quality, insulin sensitivity, and overall vitality. Because pituitary feedback remains intact, its safety profile is generally viewed as more favorable than that of exogenous HGH replacement.

Mehr aus GH peptidi

Diese Seite verwendet Cookies

Accept